NASDAQ

Inhibikase Therapeutics, Inc. (IKT)

♥ 647 Thanks from members

Live price chart, market sentiment, and community perspectives for Inhibikase Therapeutics, Inc. (NASDAQ: IKT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Dr. Leon FarhyFounder: Dr. Michael SteinmetzLeadership: Dr. Milton H. Werner (CEO)Holder: Institutional InvestorsHolder: InsidersKinase InhibitorsNeurodegenerative TherapeuticsGastrointestinal Drugs#IKT#Inhibikase Therapeutics#Biotech#NASDAQ#Kinase Inhibitors